Skip to content
Trial Eligibility
Menu

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

NCT07459673

This study is recruiting at 7 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

Thie purpose of this study is to find out whether a personalized treatment approach-using a series of ctDNA tests along with standard imaging scans to help decide when to step up (escalate) or decrease (de-escalate) sequential treatments (given one after another)-combined with local therapies (which treat cancer in a specific part of the body) and treatments that prevent cancer from spreading to the central nervous system (CNS; including the brain and spinal cord) can result in long-lasting remission and possibly cure some participants with HER2+ metastatic breast cancer.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer
  • HER2-positive Breast Cancer
  • Breast Cancer Stage IV

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Memorial Sloan Kettering Cancer Center
Last updated on ClinicalTrials.gov
August 20, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New Jersey · 3

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) · Basking Ridge, NJ
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) · Middletown, NJ
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities) · Montvale, NJ

New York · 4

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) · Commack, NY
  • Memorial Sloan Kettering at Westchester (Limited Protocol Activities) · Harrison, NY
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites) · New York, NY
  • Memorial Sloan Kettering at Nassau (Limited Protocol Activities) · Uniondale, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.